Grundlæggende statistik
| Insider-profil | Venrock Healthcare Capital Partners III, L.P. |
| Porteføljeværdi | $ 956.939.454 |
| Nuværende stillinger | 28 |
| Aktiviststillinger | 22 |
13D/G-arkivering
Dette er en liste over 13D- og 13G-arkiveringer lavet i det sidste år (hvis nogen). Klik på linkikonet for at se den fulde transaktionshistorik. Grønne rækker angiver nye positioner. Røde rækker angiver lukkede positioner.
| Fil dato | Form | Sikkerhed | Forrige Aktier |
Nuværende Aktier |
Δandele % | % Ejerskab |
% ΔEjerskab | |
|---|---|---|---|---|---|---|---|---|
| 2025-08-14 | CDTX / Cidara Therapeutics, Inc. | 1.098.996 | 639.088 | -41,85 | 3,20 | -67,68 | ||
| 2025-08-14 | PHVS / Pharvaris N.V. | 3.395.606 | 2.047.620 | -39,70 | 3,80 | -41,54 | ||
| 2025-08-14 | ZURA / Zura Bio Limited | 7.031.271 | 6.353.353 | -9,64 | 9,90 | 0,00 | ||
| 2025-08-14 | DNTH / Dianthus Therapeutics, Inc. | 1.744.373 | 1.000.000 | -42,67 | 3,10 | -47,46 | ||
| 2025-07-08 | SVRA / Savara Inc. | 9.021.507 | 5,20 | |||||
| 2025-06-23 | / (38000Q201) | 1.391.196 | 9,90 | |||||
| 2025-05-30 | ORIC / ORIC Pharmaceuticals, Inc. | 3.182.527 | 6.596.885 | 107,28 | 7,70 | 71,11 | ||
| 2025-05-20 | CTMX / CytomX Therapeutics, Inc. | 12.992.500 | 8,20 | |||||
| 2025-05-15 | MRSN / Mersana Therapeutics, Inc. | 10.257.790 | 3.574.325 | -65,16 | 2,90 | -65,06 | ||
| 2025-05-15 | APLT / Applied Therapeutics, Inc. | 11.805.301 | 5.567.709 | -52,84 | 4,10 | -58,59 | ||
| 2025-05-15 | PRAX / Praxis Precision Medicines, Inc. | 1.190.340 | 1.016.497 | -14,60 | 4,90 | -19,67 | ||
| 2025-05-15 | FDMT / 4D Molecular Therapeutics, Inc. | 2.952.371 | 677.600 | -77,05 | 1,50 | -76,56 | ||
| 2025-05-05 | JBIO / Jade Biosciences, Inc. | 3.220.369 | 9,90 | |||||
| 2025-04-02 | SRZN / Surrozen, Inc. | 872.546 | 9,90 | |||||
| 2025-02-27 | ORKA / Oruka Therapeutics, Inc. | 3.541.941 | 4.148.428 | 17,12 | 11,10 | 11,11 | ||
| 2025-02-14 | ATXS / Astria Therapeutics, Inc. | 3.458.645 | 2.457.348 | -28,95 | 4,40 | -27,87 | ||
| 2025-02-14 | ENGN / enGene Holdings Inc. | 3.565.841 | 5.046.414 | 41,52 | 9,90 | 22,22 | ||
| 2025-02-14 | IPSC / Century Therapeutics, Inc. | 5.389.259 | 3.957.186 | -26,57 | 4,70 | -26,56 | ||
| 2025-02-14 | SYRE / Spyre Therapeutics, Inc. | 2.685.448 | 2.685.448 | 0,00 | 4,60 | -13,21 | ||
| 2025-02-14 | ADVM / Adverum Biotechnologies, Inc. | 15.564.213 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-02-14 | VRDN / Viridian Therapeutics, Inc. | 3.575.309 | 3.575.309 | 0,00 | 4,50 | -18,18 | ||
| 2025-02-14 | AQST / Aquestive Therapeutics, Inc. | 5.555.555 | 2.629.786 | -52,66 | 2,90 | -55,38 | ||
| 2024-11-14 | CELC / Celcuity Inc. | 2.476.980 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | ELVN / Enliven Therapeutics, Inc. | 2.954.902 | 4.026.331 | 36,26 | 8,50 | 18,06 | ||
| 2024-11-14 | TSHA / Taysha Gene Therapies, Inc. | 10.412.872 | 9.000.000 | -13,57 | 4,40 | -21,43 | ||
| 2024-11-14 | TERN / Terns Pharmaceuticals, Inc. | 4.497.117 | 3.516.889 | -21,80 | 4,99 | -31,64 | ||
| 2024-11-14 | CABA / Cabaletta Bio, Inc. | 2.563.952 | 1.590.696 | -37,96 | 3,30 | -48,44 | ||
| 2024-11-14 | OCUL / Ocular Therapeutix, Inc. | 7.775.760 | 13.760.200 | 76,96 | 8,70 | 27,94 |
